CD8A and breast cancer: In this study, we demonstrated that SNS is efficacious and safe in treating MMD among breast cancer patients, improving quality of life and TCM syndrome scores, with the Lactobacillus-Indole-CD8+ T axis playing a potential role in the pharmacological activity of SNS.